Literature DB >> 33321823

Characterization of Salmonella Isolates from Various Geographical Regions of the Caucasus and Their Susceptibility to Bacteriophages.

Khatuna Makalatia1,2, Elene Kakabadze1,2, Jeroen Wagemans3, Nino Grdzelishvili1,4, Nata Bakuradze1,2, Gulnara Natroshvili1, Nino Macharashvili5, Anahit Sedrakyan6, Karine Arakelova6, Zhanna Ktsoyan6, Magdalina Zakharyan6, Zaruhi Gevorgyan7, Armine Mnatsakanyan8, Farida Tishkova9, Cédric Lood3,10, Dieter Vandenheuvel11, Rob Lavigne3, Jean-Paul Pirnay12, Daniel De Vos12, Nina Chanishvili1, Maia Merabishvili1,12.   

Abstract

Non-typhoidal Salmonella present a major threat to animal and human health as food-borne infectious agents. We characterized 91 bacterial isolates from Armenia and Georgia in detail, using a suite of assays including conventional microbiological methods, determining antimicrobial susceptibility profiles, matrix assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry, serotyping (using the White-Kauffmann-Le Minor scheme) and genotyping (repetitive element sequence-based PCR (rep-PCR)). No less than 61.5% of the isolates were shown to be multidrug-resistant. A new antimicrobial treatment strategy is urgently needed. Phage therapy, the therapeutic use of (bacterio-) phages, the bacterial viruses, to treat bacterial infections, is increasingly put forward as an additional tool for combatting antibiotic resistant infections. Therefore, we used this representative set of well-characterized Salmonella isolates to analyze the therapeutic potential of eleven single phages and selected phage cocktails from the bacteriophage collection of the Eliava Institute (Georgia). All isolates were shown to be susceptible to at least one of the tested phage clones or their combinations. In addition, genome sequencing of these phages revealed them as members of existing phage genera (Felixounavirus, Seunavirus, Viunavirus and Tequintavirus) and did not show genome-based counter indications towards their applicability against non-typhoidal Salmonella in a phage therapy or in an agro-food setting.

Entities:  

Keywords:  Armenia; Georgia; Salmonella; antibiotic resistance; bacteriophages; clinical isolates; foodborne pathogens; genome sequencing; genotyping; phage therapy

Year:  2020        PMID: 33321823      PMCID: PMC7764154          DOI: 10.3390/v12121418

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  28 in total

1.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Complete genomic sequence of bacteriophage felix o1.

Authors:  Jean M Whichard; Lee A Weigt; Douglas J Borris; Ling Ling Li; Qing Zhang; Vivek Kapur; F William Pierson; Erika J Lingohr; Yi-Min She; Andrew M Kropinski; Nammalwar Sriranganathan
Journal:  Viruses       Date:  2010-03-09       Impact factor: 5.818

4.  Salmonella Typhimurium-specific bacteriophage ΦSH19 and the origins of species specificity in the Vi01-like phage family.

Authors:  Steven P T Hooton; Andrew R Timms; Joanna Rowsell; Ray Wilson; Ian F Connerton
Journal:  Virol J       Date:  2011-11-02       Impact factor: 4.099

5.  Complete Genome Sequence of Salmonella enterica Serovar Typhimurium Myophage Mushroom.

Authors:  Tamra N Tolen; Yicheng Xie; Adriana C Hernandez; Gabriel F Kuty Everett
Journal:  Genome Announc       Date:  2015-04-09

Review 6.  Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.

Authors:  Agata Anna Cisek; Iwona Dąbrowska; Karolina Paulina Gregorczyk; Zbigniew Wyżewski
Journal:  Curr Microbiol       Date:  2016-11-28       Impact factor: 2.188

7.  Phage S144, A New Polyvalent Phage Infecting Salmonella spp. and Cronobacter sakazakii.

Authors:  Michela Gambino; Anders Nørgaard Sørensen; Stephen Ahern; Georgios Smyrlis; Yilmaz Emre Gencay; Hanne Hendrix; Horst Neve; Jean-Paul Noben; Rob Lavigne; Lone Brøndsted
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

8.  Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

Authors:  Maya Merabishvili; Jean-Paul Pirnay; Gilbert Verbeken; Nina Chanishvili; Marina Tediashvili; Nino Lashkhi; Thea Glonti; Victor Krylov; Jan Mast; Luc Van Parys; Rob Lavigne; Guido Volckaert; Wesley Mattheus; Gunther Verween; Peter De Corte; Thomas Rose; Serge Jennes; Martin Zizi; Daniel De Vos; Mario Vaneechoutte
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

9.  Bacteriophages and their role in food safety.

Authors:  Sanna M Sillankorva; Hugo Oliveira; Joana Azeredo
Journal:  Int J Microbiol       Date:  2012-12-18

10.  The Developing World Urgently Needs Phages to Combat Pathogenic Bacteria.

Authors:  Tobi E Nagel; Benjamin K Chan; Daniel De Vos; Ayman El-Shibiny; Erastus K Kang'ethe; Angela Makumi; Jean-Paul Pirnay
Journal:  Front Microbiol       Date:  2016-06-08       Impact factor: 5.640

View more
  5 in total

1.  Isolation, characterization, and application of a novel polyvalent lytic phage STWB21 against typhoidal and nontyphoidal Salmonella spp.

Authors:  Payel Mondal; Bani Mallick; Moumita Dutta; Shanta Dutta
Journal:  Front Microbiol       Date:  2022-08-22       Impact factor: 6.064

2.  Biological and Molecular Characterization of the Lytic Bacteriophage SoKa against Pseudomonas syringae pv. syringae, Causal Agent of Citrus Blast and Black Pit in Tunisia.

Authors:  Maroua Oueslati; Dominique Holtappels; Kiandro Fortuna; Mohamed Rabeh Hajlaoui; Rob Lavigne; Najla Sadfi-Zouaoui; Jeroen Wagemans
Journal:  Viruses       Date:  2022-09-02       Impact factor: 5.818

3.  Investigation of Salmonella Phage-Bacteria Infection Profiles: Network Structure Reveals a Gradient of Target-Range from Generalist to Specialist Phage Clones in Nested Subsets.

Authors:  Khatuna Makalatia; Elene Kakabadze; Nata Bakuradze; Nino Grdzelishvili; Ben Stamp; Ezra Herman; Avraam Tapinos; Aidan Coffey; David Lee; Nikolaos G Papadopoulos; David L Robertson; Nina Chanishvili; Spyridon Megremis
Journal:  Viruses       Date:  2021-06-28       Impact factor: 5.048

4.  Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae.

Authors:  Anaïs Eskenazi; Cédric Lood; Julia Wubbolts; Maya Hites; Nana Balarjishvili; Lika Leshkasheli; Lia Askilashvili; Leila Kvachadze; Vera van Noort; Jeroen Wagemans; Marc Jayankura; Nina Chanishvili; Mark de Boer; Peter Nibbering; Mzia Kutateladze; Rob Lavigne; Maya Merabishvili; Jean-Paul Pirnay
Journal:  Nat Commun       Date:  2022-01-18       Impact factor: 14.919

5.  In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Bacteroides fragilis Infection.

Authors:  Nata Bakuradze; Maya Merabishvili; Khatuna Makalatia; Elene Kakabadze; Nino Grdzelishvili; Jeroen Wagemans; Cedric Lood; Irakli Chachua; Mario Vaneechoutte; Rob Lavigne; Jean-Paul Pirnay; Ivane Abiatari; Nina Chanishvili
Journal:  Viruses       Date:  2021-10-11       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.